Development and validation of a liquid chromatographic method for the determination of the related substances of ramipril in Altace capsules

Journal of Pharmaceutical and Biomedical Analysis

Volumn 23, Issue 4, 2000, Pages 637-651

  Hogan, Barry L ^a   Williams, Mark ^a   Idiculla, Anna ^a   Veysoglu, Tarik ^a   Parente, Ernest ^a  

^a Aventis Pharmaceuticals   (United States)

Author keywords

Altace; Liquid chromatography; Method development; Ramipril; Related substances

Indexed keywords

RAMIPRIL; SODIUM PERCHLORATE;

ACCURACY; ARTICLE; DRUG CAPSULE; DRUG DETERMINATION; DRUG STABILITY; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SPECTRAL SENSITIVITY; STEREOISOMERISM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPSULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; INDICATORS AND REAGENTS; RAMIPRIL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0034284135     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(00)00342-3     Document Type: Article

References (7)

1. Bonazzi D., Gotti R., Andrisano V., Cavrini V. J. Pharm. Biomed. Anal. 16:1997;431-438.
2. Eckert H.G., Munscher G., Oekonomopulos R., Strecker H., Urbach H., Wissmann H. Arzneim.-Forsch./Drug Res. 35:1985;1251-1256.
3. Ito M., Kuriki T., Goto J., Nambara T. J. Liq. Chromatogr. 13:1990;991-1000.
4. Aboul-Enein H.Y., Bunaciu A.A., Bala C., Fleschin S. Anal. Lett. 30:1997;1997-2008.
5. Sereda K.M., Hardman T.C., Dilloway M.R., Lant A.F. Anal. Proc. 30:1993;371-372.
6. Aboul-Enein H.Y., Bakr S.A. Drug Dev. Ind. Pharm. 18:1992;1013-1022.
7. Aboul-Enein H.Y., Thiffault C. Anal. Lett. 24:1991;2217-2224.